Free Trial
NASDAQ:DERM

Journey Medical (DERM) Stock Price, News & Analysis

Journey Medical logo
$7.10 +0.06 (+0.85%)
As of 07/3/2025 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Journey Medical Stock (NASDAQ:DERM)

Key Stats

Today's Range
$7.00
$7.28
50-Day Range
$5.97
$8.07
52-Week Range
$3.54
$8.25
Volume
84,240 shs
Average Volume
89,524 shs
Market Capitalization
$165.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$9.50
Consensus Rating
Buy

Company Overview

Journey Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
33rd Percentile Overall Score

DERM MarketRank™: 

Journey Medical scored higher than 33% of companies evaluated by MarketBeat, and ranked 2254th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Journey Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Journey Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about Journey Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Journey Medical are expected to grow in the coming year, from ($1.02) to ($0.23) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Journey Medical is -18.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Journey Medical is -18.21, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Journey Medical has a P/B Ratio of 7.80. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Journey Medical's valuation and earnings.
  • Percentage of Shares Shorted

    6.24% of the float of Journey Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Journey Medical has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Journey Medical has recently increased by 39.60%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Journey Medical does not currently pay a dividend.

  • Dividend Growth

    Journey Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    6.24% of the float of Journey Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    Journey Medical has a short interest ratio ("days to cover") of 5.3.
  • Change versus previous month

    Short interest in Journey Medical has recently increased by 39.60%, indicating that investor sentiment is decreasing significantly.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Journey Medical this week, compared to 2 articles on an average week.
  • Search Interest

    Only 1 people have searched for DERM on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • MarketBeat Follows

    1 people have added Journey Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Journey Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $52,606.00 in company stock.

  • Percentage Held by Insiders

    15.03% of the stock of Journey Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 7.25% of the stock of Journey Medical is held by institutions.

  • Read more about Journey Medical's insider trading history.
Receive DERM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Journey Medical and its competitors with MarketBeat's FREE daily newsletter.

DERM Stock News Headlines

Journey Medical Corporation (DERM) - Yahoo Finance
Journey Medical (NASDAQ:DERM) Raised to "Buy" at Wall Street Zen
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

DERM Stock Analysis - Frequently Asked Questions

Journey Medical's stock was trading at $3.91 at the start of the year. Since then, DERM stock has increased by 81.6% and is now trading at $7.10.

Journey Medical Corporation (NASDAQ:DERM) issued its quarterly earnings data on Wednesday, May, 14th. The company reported ($0.18) earnings per share for the quarter, beating analysts' consensus estimates of ($0.24) by $0.06. The firm had revenue of $13.14 million for the quarter, compared to analyst estimates of $12.05 million. Journey Medical had a negative trailing twelve-month return on equity of 52.03% and a negative net margin of 14.76%.
Read the conference call transcript
.

Journey Medical (DERM) raised $39 million in an initial public offering (IPO) on Friday, November 12th 2021. The company issued 3,520,000 shares at a price of $10.00-$12.00 per share.

Shares of DERM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Journey Medical investors own include Broadcom (AVGO), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), ServiceNow (NOW), Adobe (ADBE) and AppLovin (APP).

Company Calendar

Last Earnings
5/14/2025
Today
7/04/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:DERM
Previous Symbol
NASDAQ:DERM
Fax
N/A
Employees
90
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$9.50
High Stock Price Target
$10.50
Low Stock Price Target
$9.00
Potential Upside/Downside
+33.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$14.67 million
Pretax Margin
-14.65%

Debt

Sales & Book Value

Annual Sales
$56.13 million
Price / Cash Flow
N/A
Book Value
$0.91 per share
Price / Book
7.80

Miscellaneous

Free Float
19,795,000
Market Cap
$165.43 million
Optionable
N/A
Beta
0.80
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:DERM) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners